Sponsors / UPB
UPB

Upstream Bio Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
4Trials in this database
9Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal PolypsNCT06164704UPBPhase 2Completed2025-07-07Actual
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)NCT06196879UPBPhase 2Completed2025-12-16Actual
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479UPBPhase 2Active not recruiting2027-09Estimated
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078UPBPhase 2Active not recruiting2027-10Estimated

Latest recorded trial changes